ReShape Lifesciences Inc (ReShape) formerly Obalon Therapeutics Inc, designs, develops and commercializes minimally invasive medical devices to treat obesity and metabolic diseases. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. ReShape Vest system is a implanted device allows weight reduction while keeping the stomach in place. It provides ReShapeCare virtual health coaching programme, which encourages healthy lifestyle modifications for all patients undergoing medically assisted weight reduction, and ReShape Diabetes Bloc-Stim Neuromodulation, a preclinical technology being developed for the treatment of type 2 diabetes mellitus. ReShape is headquartered in San Clemente, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ReShape Lifesciences Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- ReShape Lifesciences Inc Company Overview
- ReShape Lifesciences Inc Company Snapshot
- ReShape Lifesciences Inc Pipeline Products and Ongoing Clinical Trials Overview
- ReShape Lifesciences Inc - Pipeline Analysis Overview
- ReShape Lifesciences Inc - Key Facts
- ReShape Lifesciences Inc - Major Products and Services
- ReShape Lifesciences Inc Pipeline Products by Development Stage
- ReShape Lifesciences Inc Pipeline Products Overview
- Diabetes Bloc-Stim Neuromodulation Device
- Diabetes Bloc-Stim Neuromodulation Device Product Overview
- Diabetes Bloc-Stim Neuromodulation Device - Hypoglycemia
- Diabetes Bloc-Stim Neuromodulation Device - Hypoglycemia Product Overview
- Maestro RF System
- Maestro RF System Product Overview
- Patient Compliance System
- Patient Compliance System Product Overview
- ReShape Vest
- ReShape Vest Product Overview
- ReShape Lifesciences Inc - Key Competitors
- ReShape Lifesciences Inc - Key Employees
- ReShape Lifesciences Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- ReShape Lifesciences Inc, Recent Developments
- Nov 12, 2024: Reshape Lifesciences Receives Health Canada Approval for Its Next-Generation Lap-Band 2.0 Flex
- Nov 11, 2024: ReShape Lifesciences Receives NIH Supplementary Grant with the University of Southern California’s Center for Autonomic Nerve Recording and Stimulation Systems (CARSS) to Further Develop Next-Generation Electrodes for ReShape’s Proprietary Diabetes B
- Mar 28, 2024: Reshape Lifesciences Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
- Mar 04, 2024: ReShape Lifesciences Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band 2.0 FLEX
- Feb 22, 2024: Reshape Lifesciences Announces First Surgeries Utilizing Next-Generation Lap-Band 2.0 Flex
- Jan 24, 2024: ReShape Lifesciences Conducts Bariatric Fellows Training for its Lap-Band System, Highlighting the Next-Generation Lap-Band 2.0 FLEX
- Dec 12, 2023: ReShape Lifesciences Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band 2.0 FLEX
- Nov 06, 2023: ReShape Lifesciences to Announce Financial Results for the Third Quarter Ended September 30, 2023 and Provide Corporate Update
- Sep 22, 2023: ReShape Lifesciences Announces Participation in the LD Micro Main Event XVI
- Sep 19, 2023: ReShape Lifesciences Significantly Strengthens Patent Portfolio Related to its Obalon Balloon System
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- ReShape Lifesciences Inc Pipeline Products and Ongoing Clinical Trials Overview
- ReShape Lifesciences Inc Pipeline Products by Equipment Type
- ReShape Lifesciences Inc Pipeline Products by Indication
- ReShape Lifesciences Inc, Key Facts
- ReShape Lifesciences Inc, Major Products and Services
- ReShape Lifesciences Inc Number of Pipeline Products by Development Stage
- ReShape Lifesciences Inc Pipeline Products Summary by Development Stage
- Diabetes Bloc-Stim Neuromodulation Device - Product Status
- Diabetes Bloc-Stim Neuromodulation Device - Product Description
- Diabetes Bloc-Stim Neuromodulation Device - Hypoglycemia - Product Status
- Diabetes Bloc-Stim Neuromodulation Device - Hypoglycemia - Product Description
- Maestro RF System - Product Status
- Maestro RF System - Product Description
- Patient Compliance System - Product Status
- Patient Compliance System - Product Description
- ReShape Vest - Product Status
- ReShape Vest - Product Description
- ReShape Lifesciences Inc, Key Employees
- ReShape Lifesciences Inc, Subsidiaries
- Glossary
- ReShape Lifesciences Inc Pipeline Products by Equipment Type
- ReShape Lifesciences Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Orexigen Therapeutics Inc
- Morphic Medical Inc
- Acutus Medical Inc
